
As the spread of Ebola continues in Central and Eastern Africa, the cumulative number of confirmed cases in Kenya increased to 8, and in the Democratic Republic of Congo, the epicenter, a new state was confirmed to be infected.
AI-generated summary
The Ebola virus is spreading in Central and Eastern Africa, and confirmed cases and deaths are occurring in Democratic Congo and Kenya.
The spread of Ebola is not slowing down in Central and Eastern Africa.
In Kenya, where the first confirmed case occurred early this month, the total number of confirmed cases increased to eight in two weeks, and in the Democratic Republic of the Congo, the epicenter, an infected person was confirmed in the eighth province where there had been no confirmed cases so far.
According to Reuters on the 19th (local time), Patrick Amos, Director-General of Kenya's Ministry of Health, said in a local TV interview the night before that an additional 49-year-old man tested positive for Ebola, bringing the total number of confirmed Ebola cases in the country to eight.
It is presumed that the new confirmed patient was highly likely to have been exposed to the virus as he worked as a patient assistant at the hospital where Kenya's first confirmed Ebola patient, who died on the 5th, was admitted, and was responsible for handling laundry such as medical equipment and bedding.
He was quarantined on the 9th and tested positive for Ebola after showing symptoms such as fever, headache, and muscle pain.
In Kenya, the first confirmed case of Ebola, who returned from Democratic Congo via Uganda, died on the 5th, and 128 of the 130 people, including family members, relatives, and medical staff who came into contact with him, have been identified and are being quarantined. So far, 7 additional contacts have been confirmed, including 3 family members and relatives, 3 medical staff, and 1 hospital support staff, and there have been no deaths other than the first confirmed case.
In the Democratic Congo, the Ministry of Health of the Democratic Congo announced the previous day that two people were confirmed in Northern Ubangui Province, where there had been no confirmed cases until now, and one of them died.
These confirmed patients were all men in their 20s and reportedly lived in the Wapinda Health Administrative Area in Northern Ubangui Province, adjacent to Bauele Province, which was previously classified as an Ebola outbreak area.
EFE news agency reported that in Democratic Congo, since the Ebola outbreak was declared on May 15, the cumulative number of Ebola confirmed cases was 9,415 as of the 16th of this month.
Of these, 4,536 people died, resulting in a fatality rate of 48.2%.

In response to the government's amendment to the enforcement rules of the Non-face-to-face Medical Treatment Act, the Korean Pharmaceutical Association on the 19th called for strengthening the limit on the number of days to prescribe for first and second visits and including the prohibition on prescribing emergency contraceptives.

The Korean Medical Association called for a full reexamination of the government's proposed amendment to the enforcement rules of the Medical Service Act related to non-face-to-face treatment, saying it violates existing promises, such as the principle of face-to-face treatment, and announced that it would carefully review whether to participate if the amendment is enforced.

Cheongju City announced on the 19th that it will provide free flu vaccine from the 22nd of this month to December 12th for residents aged 60 to 64, those aged 50 or older, recipients of basic livelihood security, and the lowest income class, who are not eligible for national vaccination.

According to the Korea Disease Control and Prevention Agency, the flu vaccination rate for seniors over 65 years old was 45.8% and for children 43.7%. Although the vaccination rate for children increased compared to the same period last year, it remains at about half of the total.

The Ministry of Food and Drug Safety attempted to designate the GLP-1 series of obesity treatments as drugs of concern for abuse, but the process has been delayed due to delays in deliberation by the Regulatory Rationalization Committee. Experts are urging the development of an effective management plan rather than simply assigning a name, and there is also speculation that the approval of the domestically produced new drug Epee could affect the designation discussions.

Last year, Chuna therapy treatment expenses combined with health insurance and auto insurance amounted to 684.9 billion won, an increase of 60% compared to 2021. In particular, 188 cases of claims per year for the same patient were found in auto insurance, raising the need to manage excessive treatment.